Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Optimization of right ventricular lead position in cardiac resynchronisation therapy

L Riedlbauchova, R Cihak, J Bytesnik, V Vancura, P Fridl, L Hoskova, J Kautzner

. 2006 ; 8 (6) : 609-614.

Language English Country Netherlands

Grant support
NR8541 MZ0 CEP Register

BACKGROUND: The benefit of biventricular pacing (BiV) may be substantially affected by optimal lead placement. AIM: To evaluate the importance of right ventricular (RV) lead positioning on clinical outcome of BiV. METHODS AND RESULTS: A total of 99 patients with symptomatic heart failure and implantation of BiV system were included. Position of the left-ventricular (LV) lead was selected based on timing of local endocardial signal within the terminal portion of the QRS complex. RV lead was preferably positioned at the midseptum (n=74, RVS group) where the earliest RV endocardial signal was recorded. A subgroup of patients had RV lead placed in the apex (n=25, RVA group). NYHA class, maximum oxygen-uptake (VO(2)max), LV end-diastolic diameter (LVEDD, mm) and ejection fraction were assessed every third month. A trend towards greater improvement in NYHA class and significant increase in VO(2)max was present in the RVS group. Moreover, a significant decrease in LVEDD (DeltaLVEDD) was observed in the RVS group only (-3.4+/-6.5 mm versus +1.7+/-6.4 mm in RVA group at 12 months, p=0.004). No significant correlation between the degree of DeltaLVEDD and QRS narrowing induced by BiV was found. LVEDD reduction was predominantly present in dilated cardiomyopathy. CONCLUSIONS: Midseptal positioning of the RV lead appears to promote reverse LV remodelling during cardiac resynchronisation therapy.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13032000
003      
CZ-PrNML
005      
20131002143759.0
007      
ta
008      
131002s2006 ne a f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejheart.2005.11.009 $2 doi
035    __
$a (PubMed)16504581
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a ne
100    1_
$a Riedlbauchová, Lucie, $d 1976- $7 xx0109046 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Optimization of right ventricular lead position in cardiac resynchronisation therapy / $c L Riedlbauchova, R Cihak, J Bytesnik, V Vancura, P Fridl, L Hoskova, J Kautzner
504    __
$a Literatura
520    9_
$a BACKGROUND: The benefit of biventricular pacing (BiV) may be substantially affected by optimal lead placement. AIM: To evaluate the importance of right ventricular (RV) lead positioning on clinical outcome of BiV. METHODS AND RESULTS: A total of 99 patients with symptomatic heart failure and implantation of BiV system were included. Position of the left-ventricular (LV) lead was selected based on timing of local endocardial signal within the terminal portion of the QRS complex. RV lead was preferably positioned at the midseptum (n=74, RVS group) where the earliest RV endocardial signal was recorded. A subgroup of patients had RV lead placed in the apex (n=25, RVA group). NYHA class, maximum oxygen-uptake (VO(2)max), LV end-diastolic diameter (LVEDD, mm) and ejection fraction were assessed every third month. A trend towards greater improvement in NYHA class and significant increase in VO(2)max was present in the RVS group. Moreover, a significant decrease in LVEDD (DeltaLVEDD) was observed in the RVS group only (-3.4+/-6.5 mm versus +1.7+/-6.4 mm in RVA group at 12 months, p=0.004). No significant correlation between the degree of DeltaLVEDD and QRS narrowing induced by BiV was found. LVEDD reduction was predominantly present in dilated cardiomyopathy. CONCLUSIONS: Midseptal positioning of the RV lead appears to promote reverse LV remodelling during cardiac resynchronisation therapy.
590    __
$a bohemika - dle Pubmed
650    12
$a Cardiac Output, Low $x th [Therapy]
650    12
$a Cardiac Pacing, Artificial $x mt [Methods]
650    02
$a Chronic Disease
650    02
$a Electrodes, Implanted
650    02
$a Female
650    12
$a Heart Septum $x ir [Innervation]
650    12
$a Heart Ventricles $x ir [Innervation]
650    _2
$a lidé $7 D006801
650    02
$a Hypertrophy, Left Ventricular $x pc [Prevention & Control]
650    02
$a Male
650    02
$a Middle Aged
650    12
$a Pacemaker, Artificial
650    02
$a Prospective Studies
650    02
$a Ventricular Remodeling
700    1_
$a Čihák, Robert $7 xx0061374 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Bytešník, Jan, $d 1947- $7 jn20000400328 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Vančura, Vlastimil $7 xx0060367 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Frídl, Petr $7 xx0059974 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hošková, Lenka $7 xx0076892 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kautzner, Josef, $d 1957- $7 xx0037112 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$t European Journal of Heart Failure $x 1388-9842 $g Roč. 8, č. 6 (2006), s. 609-614 $p Eur J Heart Fail $w MED00006634
773    0_
$p Eur J Heart Fail $g 8(6):609-14, 2006 Oct $x 1388-9842
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20131002144317 $b ABA008
991    __
$a 20131002144317 $b ABA008
999    __
$a ok $b bmc $g 996086 $s 830448
BAS    __
$a 3
BMC    __
$a 2006 $b 8 $c 6 $d 609-614 $i 1388-9842 $m European journal of heart failure $x MED00006634 $n Eur J Heart Fail
GRA    __
$a NR8541 $p MZ0
LZP    __
$a 2013-10/išbo

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...